Level Financial Advisors, Inc. Johnson & Johnson Transaction History

Level Financial Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$145.6 - $158.88 $7,280 - $7,944	-50 Reduced 11.9%	370 $57,000
Q3 2023 Oct 18, 2023	SELL	$155.75 - $174.48 $13,861 - $15,528	-89 Reduced 17.49%	420 $65,000
Q2 2023 Jul 14, 2023	BUY	$154.35 - $166.11 $771 - $830	5 Added 0.99%	509 $84,000
Q1 2023 Apr 10, 2023	SELL	$151.05 - $180.26 $4,833 - $5,768	-32 Reduced 5.97%	504 $78,000
Q4 2022 Jan 23, 2023	SELL	$160.2 - $179.79 $9,131 - $10,248	-57 Reduced 9.61%	536 $0
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $1,290 - $1,436	8 Added 1.37%	593 $97,000
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $4,541 - $5,022	27 Added 4.84%	585 $104,000
Q1 2022 Apr 08, 2022	SELL	$158.14 - $179.59 $10,437 - $11,852	-66 Reduced 10.58%	558 $99,000
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $97,300 - $107,958	624 New	624 $107,000

4,253

1.68B

14M

11.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Level Financial Advisors, Inc. with notifications on news.